Ex parte GAFFAR et al. - Page 7




          Appeal No. 1995-4903                                                        
          Application No. 07/926,016                                                  


               As an initial matter, appellants submit that the claims                
          do not stand or fall together.  Appellants’ argument on behalf              
          of separate consideration of three Groups of claims appears in              
          the Brief, page 3.  Group I is directed to rejections relating              
          to the antibacterial agent chlorhexidine.  Group II is                      
          directed to rejections related to the antibacterial agent                   
          triclosan.  Group III is directed to claim 15 and adds an                   
          additional component, i.e. a polymeric polycarboxylate.  Since              
          each of the Groups I and II are encompassed by claim 1, and                 
          claim 15 is dependent on claim 1, we will limit our                         
          consideration to claims 1 and 15 as we have determined that it              
          is dispositive of each of the issues before us.                             
               We have carefully considered all of the arguments                      
          advanced by appellants and the examiner.  We agree with                     
          appellants that the aforementioned rejections over Vinson and               
          Ploger (I-II), combined in view of Irani, Parran, Gaffar and                
          further in view of Henkel and Kanebo and the rejection over de              
          Vries and Hayes,(I-II)on the grounds of anticipation is not                 
          well founded.  Accordingly, we will not sustain those                       
          rejections.                                                                 


                                          7                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007